<code id='C92994F960'></code><style id='C92994F960'></style>
    • <acronym id='C92994F960'></acronym>
      <center id='C92994F960'><center id='C92994F960'><tfoot id='C92994F960'></tfoot></center><abbr id='C92994F960'><dir id='C92994F960'><tfoot id='C92994F960'></tfoot><noframes id='C92994F960'>

    • <optgroup id='C92994F960'><strike id='C92994F960'><sup id='C92994F960'></sup></strike><code id='C92994F960'></code></optgroup>
        1. <b id='C92994F960'><label id='C92994F960'><select id='C92994F960'><dt id='C92994F960'><span id='C92994F960'></span></dt></select></label></b><u id='C92994F960'></u>
          <i id='C92994F960'><strike id='C92994F960'><tt id='C92994F960'><pre id='C92994F960'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:667
          President Joe Biden speaks at a campaign event at Pullman Yards on March 9, 2024 in Atlanta, Georgia.
          President Biden speaks at a campaign event in Atlanta this month. Megan Varner/Getty Images

          WASHINGTON — President Biden on Monday unveiled his requests for the 2025 budget, potentially his last chance to cement a legacy on drug costs, cancer research, and broad health care coverage.

          The president’s $130.7 billion proposal is a dip from the $144.3 billion requested for this financial year and a nod to the tough line Congress has taken on government spending.

          advertisement

          Biden also designed the plan to grab the attention of voters. While presidential budget proposals always include a long list of priorities that are unlikely to become law, Biden’s budget aims to show voters what they’d get in return for keeping him in office and voting in a Democratic-controlled Congress, including lower health care costs, expanded insurance coverage, and beefed up cybersecurity for hospitals.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Albert Bourla of Pfizer: worst biopharma CEO of 2023
          Albert Bourla of Pfizer: worst biopharma CEO of 2023

          HyacinthEmpinado/STATPfizeristhisyear’santi-EliLilly.IfDavidRicksisthebestbiopharmaCEOof2023,thenPfi

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons